Trevi Therapeutics, Inc. <TRVI.O>: Oppenheimer Raises Target Price to $25 From $24
TRVI•Related News
abrdn Asia-Pacific Income Fund NAV at $ 5.39 as of Aug. 6, 2026
FAX•
US Foods Holding Corp. <USFD.N>: UBS Raises Target Price to $127 From $117
USFD•
HA Sustainable Infrastructure Capital Inc <HASI.N>: UBS raises target price to $51 from $50
HASI•
Roku, Inc. <ROKU.O>: UBS Raises Target Price to $172 From $126
ROKU•
Pilgrim's Pride Corp <PPC.O>: UBS cuts target price to $28 from $30
PPC•